A novel function for cadherin 11/osteoblast-cadherin in vascular smooth muscle cells: Modulation of cell migration and proliferation

Journal of Vascular Surgery

Volumn 45, Issue 3, 2007, Pages 581-589

  Monahan, Thomas S ^a   Andersen, Nicholas D ^b   Panossian, Haig ^a   Kalish, Jeffrey A ^c   Daniel, Soizic ^a   Shrikhande, Gautam V ^a   Ferran, Christiane ^a   LoGerfo, Frank W ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NERVE CELL ADHESION MOLECULE; NERVE CELL ADHESION MOLECULE 11; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CEPHALIC VEIN; CONTROLLED STUDY; CORONARY ARTERY; GENE SILENCING; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE; VASCULAR SURGERY; VEIN GRAFT;

ANASTOMOSIS, SURGICAL; ANIMALS; ANTIBODIES; CADHERINS; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CORONARY VESSELS; DOGS; FEMORAL ARTERY; HUMANS; HYPERPLASIA; MODELS, ANIMAL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; VEINS;

EID: 33847167429     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2006.12.016     Document Type: Article

References (34)

1. Davies M.G., and Hagen P.O. Pathophysiology of vein graft failure: a review. Eur J Vasc Endovasc Surg 9 (1995) 7-18
2. Schwartz S.M., deBlois D., and O'Brien E.R. The intima. Soil for atherosclerosis and restenosis. Circ Res 77 (1995) 445-465
3. Stegemann J.P., and Nerem R.M. Phenotype modulation in vascular tissue engineering using biochemical and mechanical stimulation. Ann Biomed Eng 31 (2003) 391-402
4. Jovinge S., Hultgardh-Nilsson A., Regnstrom J., and Nilsson J. Tumor necrosis factor-alpha activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta. Arterioscler Thromb Vasc Biol 17 (1997) 490-497
5. Lindner V., and Reidy M.A. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci U S A 88 (1991) 3739-3743
6. Kalish J.A., Willis D.J., Li C., Link J.J., Deutsch E.R., Contreras M.A., et al. Temporal genomics of vein bypass grafting through oligonucleotide microarray analysis. J Vasc Surg 39 (2004) 645-654
7. Willis D.J., Kalish J.A., Li C., Deutsch E.R., Contreras M.A., LoGerfo F.W., et al. Temporal gene expression following prosthetic arterial grafting. J Surg Res 120 (2004) 27-36
8. Angst B.D., Marcozzi C., and Magee A.I. The cadherin superfamily: diversity in form and function. J Cell Sci 114 (2001) 629-641
9. Okazaki M., Takeshita S., Kawai S., Kikuno R., Tsujimura A., Kudo A., et al. Molecular cloning and characterization of OB-cadherin, a new member of cadherin family expressed in osteoblasts. J Biol Chem 269 (1994) 12092-12098
10. Tanihara H., Sano K., Heimark R.L., St John T., and Suzuki S. Cloning of five human cadherins clarifies characteristic features of cadherin extracellular domain and provides further evidence for two structurally different types of cadherin. Cell Adhes Commun 2 (1994) 15-26
11. Kii I., Amizuka N., Shimomura J., Saga Y., and Kudo A. Cell-cell interaction mediated by cadherin-11 directly regulates the differentiation of mesenchymal cells into the cells of the osteo-lineage and the chondro-lineage. J Bone Miner Res 19 (2004) 1840-1849
12. Feltes C.M., Kudo A., Blaschuk O., and Byers S.W. An alternatively spliced cadherin-11 enhances human breast cancer cell invasion. Cancer Res 62 (2002) 6688-6697
13. Pishvaian M.J., Feltes C.M., Thompson P., Bussemakers M.J., Schalken J.A., and Byers S.W. Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res 59 (1999) 947-952
14. Tomita K., van Bokhoven A., van Leenders G.J., Ruijter E.T., Jansen C.F., Bussemakers M.J., et al. Cadherin switching in human prostate cancer progression. Cancer Res 60 (2000) 3650-3654
15. Markus M.A., Reichmuth C., Atkinson M.J., Reich U., Hoffmann I., Balling R., et al. Cadherin-11 is highly expressed in rhabdomyosarcomas and during differentiation of myoblasts in vitro. J Pathol 187 (1999) 164-172
16. Quist W.C., and LoGerfo F.W. Prevention of smooth muscle cell phenotypic modulation in vein grafts: a histomorphometric study. J Vasc Surg 16 (1992) 225-231
17. Hamdan A.D., Aiello L.P., Misare B.D., Contreras M.A., King G.L., LoGerfo F.W., et al. Vascular endothelial growth factor expression in canine peripheral vein bypass grafts. J Vasc Surg 26 (1997) 79-86
18. Bustin S.A. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 29 (2002) 23-39
19. Gross A., Yin X.M., Wang K., Wei M.C., Jockel J., Milliman C., et al. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 274 (1999) 1156-1163
20. Voytik-Harbin S.L., Brightman A.O., Waisner B., Lamar C.H., and Badylak S.F. Application and evaluation of the alamarBlue assay for cell growth and survival of fibroblasts. In Vitro Cell Dev Biol Anim 34 (1998) 239-246
21. Zhang L., Peppel K., Brian L., Chien L., and Freedman N.J. Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells. Arterioscler Thromb Vasc Biol 24 (2004) 2277-2283
22. Faries P.L., Marin M.L., Veith F.J., Ramirez J.A., Suggs W.D., Parsons R.E., et al. Immunolocalization and temporal distribution of cytokine expression during the development of vein graft intimal hyperplasia in an experimental model. J Vasc Surg 24 (1996) 463-471
23. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
24. Nagano H., Mitchell R.N., Taylor M.K., Hasegawa S., Tilney N.L., and Libby P. Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest 100 (1997) 550-557
25. Rectenwald J.E., Moldawer L.L., Huber T.S., Seeger J.M., and Ozaki C.K. Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation 102 (2000) 1697-1702
26. Tintut Y., Patel J., Parhami F., and Demer L.L. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102 (2000) 2636-2642
27. Doucas H., Garcea G., Neal C.P., Manson M.M., and Berry D.P. Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance. Eur J Cancer 41 (2005) 365-379
28. Gavert N., Conacci-Sorrell M., Gast D., Schneider A., Altevogt P., Brabletz T., et al. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 168 (2005) 633-642
29. Kudrjashova E., Bashtrikov P., Bochkov V., Parfyonova Y., Tkachuk V., Antropova J., et al. Expression of adhesion molecule T-cadherin is increased during neointima formation in experimental restenosis. Histochem Cell Biol 118 (2002) 281-290
30. Ivanov D., Philippova M., Antropova J., Gubaeva F., Iljinskaya O., Tararak E., et al. Expression of cell adhesion molecule T-cadherin in the human vasculature. Histochem Cell Biol 115 (2001) 231-242
31. Ivanov D., Philippova M., Allenspach R., Erne P., and Resink T. T-cadherin upregulation correlates with cell-cycle progression and promotes proliferation of vascular cells. Cardiovasc Res 64 (2004) 132-143
32. Song E., Lee S.K., Wang J., Ince N., Ouyang N., Min J., et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 9 (2003) 347-351
33. Mann M.J., Gibbons G.H., Hutchinson H., Poston R.S., Hoyt E.G., Robbins R.C., et al. Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues. Proc Natl Acad Sci U S A 96 (1999) 6411-6416
34. Brown D.J., Rzucidlo E.M., Merenick B.L., Wagner R.J., Martin K.A., and Powell R.J. Endothelial cell activation of the smooth muscle cell phosphoinositide 3-kinase/Akt pathway promotes differentiation. J Vasc Surg 41 (2005) 509-516